Peripheral arterial disease

Original Research

Examining Sex-Based Differences Among Individuals With Peripheral Arterial Disease in Southwest Louisiana: A Secondary Data Analysis

02/16/2023

Jennifer Lemoine, PhD, DNP, APRN¹; Barbara L. Wilson, PhD, RNC-OB, FAAN²; Katherine Sward, PhD, RN²; Richard J. Butler, PhD³

¹University of Louisiana at Lafayette, Lafayette, Louisiana; ²University of Utah, Salt Lake City, Utah; ³Brigham Young University, Provo, Utah

Jennifer Lemoine, PhD, DNP, APRN1; Ba...

Exploring the relationship between sex and determinants of PAD and symptom severity, treatments offered, and outcomes.

Exploring the relationship...

02/16/2023

Vascular Disease Management

Editor's Corner

BEST-CLI Deep Dive II

12/15/2022

Craig Walker, MD, FACC, FACP

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD, FACC, FACP C...

Dr. Walker continues his discussion of the BEST-CLI randomized control trial comparing surgery-first with or without an adequate venous conduit vs endovascular-first treatment in patients with CLTI.

Dr. Walker continues his...

12/15/2022

Vascular Disease Management

Original Research

Post-market, Prospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium Used as a Patch in Vascular Repair and Reconstruction Surgery: PHOTO-V

12/14/2022

Nicholas Morrissey, MD¹; B. Timothy Baxter, MD²; Michael Belkin, MD³; William T. Bohannon, MD, FACS⁴; Jose Borromeo, MD, FACS⁵; Nitin Garg, MBBS, MPH⁶; Larry Kraiss, MD⁷; Nicholas Osborne, MD⁸; Todd Russell, MD, FACS⁹; Wei Zhou, MD¹⁰

¹Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, Division of Vascular Surgery and Endovascular Interventions, New York, New York; ²University of Nebraska Medical Center, Omaha, Nebraska; ³Brigham & Women's Hospital, Boston, Massachusetts; ⁴Baylor Scott & White, Temple, Texas; ⁵Iowa Heart Center, West Des Moines, Iowa; ⁶Peak Heart and Vascular, Avondale, Arizona; ⁷University of Utah School of Medicine, Salt Lake City, Utah; ⁸University of Michigan, Ann Arbor, Michigan; ⁹Jobst Vascular Institute, Toledo, Ohio; ¹⁰University of Arizona, Tucson, Arizona

Nicholas Morrissey, MD1; B. Timothy B...

This article reports the results from the first clinical study of a BPP processed through photo-oxidation, without the use of glutaraldehyde, in procedures for CAS, as well as PAD.

This article reports the results...

12/14/2022

Vascular Disease Management

OBL Corner

The Value of Outpatient Based Labs for Endovascular Therapy of Peripheral Artery Disease: The Cardiovascular Institute of the South Experience

11/16/2022

Sarah Melvin, MSPH; Pradeep Nair, MD

Cardiovascular Institute of the South, Houma, Louisiana

Sarah Melvin, MSPH; Pradeep Nair, MD ...

A review of the safety, efficacy, and outcomes of lower extremity endovascular intervention in patients with symptomatic PAD.

A review of the safety,...

11/16/2022

Vascular Disease Management

Marmagkiolis Endovascular Therapy Table 1

Original Contribution

Superficial Femoral Artery Endovascular Therapy: 12-Month Primary Patency Rates of Contemporary Endovascular Devices from 25,051 Patients

10/20/2022

Konstantinos Marmagkiolis, MD^1,2; Ismail Dogu Kilic, MD³; İbrahim Halil Inanc, MD⁴; Cezar Iliescu, MD¹; Muhammad Ajmal⁵; Mehmet Cilingiroglu, MD¹

Konstantinos Marmagkiolis, MD1,2; Is...

Approximately 5.8 million people experience peripheral arterial disease (PAD) in the United States today. Superficial femoral artery (SFA) disease is the most common cause of symptomatic PAD. New-generation nitinol stents, drug-coated stents,...

Approximately 5.8 million people...

10/20/2022

Journal of Invasive Cardiology

Commentary

Is There a Role for Edetate Disodium Chelation in PAD and Specifically CLTI?

10/12/2022

Francisco Ujueta, MD, MS¹; Gervasio A. Lamas, MD^1,2

¹Columbia University Division of Cardiology, Mount Sinai Medical Center, Miami Beach, Florida; ²Department of Medicine, Mount Sinai Medical Center, Miami Beach, Florida

Francisco Ujueta, MD, MS1; Gervasio A...

In this commentary, the authors review edetate disodium chelation therapy and its use in patients with PAD and CLTI.

In this commentary, the authors...

10/12/2022

Vascular Disease Management

Scientific Abstracts

Abstracts From the Amputation Prevention Symposium (AMP), August 17-20, 2022, Chicago, Illinois

09/20/2022

Read the abstracts that were submitted to AMP, which took place August 17-20, 2022, in Chicago, Illinois. These abstracts cover a variety of topics, with a focus on PAD, CLI, and amputation prevention.

Read the abstracts that were...

09/20/2022

Vascular Disease Management

Interview and Case Report

Treating Calcified PAD With the New Shockwave M5+ IVL Catheter

07/06/2022

Halim Yammine, MD

Sanger Heart and Vascular Institute, Atrium Health, Charlotte, North Carolina

Halim Yammine, MD Sanger Heart...

VDM speaks with vascular surgeon Halim Yammine, MD, about treating calcified PAD with the Shockwave M5+ IVL catheter.

VDM speaks with vascular surgeon...

07/06/2022

Vascular Disease Management

Interview and Case Report

Broaden Access Options With the Longer Shockwave M5+ 135cm Catheter

06/01/2022

Amit Srivastava, MD, FACC, FABVM

Bay Area Heart Cardiac, Vascular, and Vein Center, St. Petersburg, Florida

Amit Srivastava, MD, FACC, FABVM ...

VDM speaks with interventional cardiologist Amit Srivastava, MD, from Bay Area Heart Cardiac, Vascular, and Vein Center.

VDM speaks with interventional...

06/01/2022

Vascular Disease Management

Original Research

Edetate Disodium Infusions May Benefit Patients With Diabetes and Critical Limb-Threatening Ischemia

05/16/2022

Francisco Ujueta, MD, MS¹; Ivan A. Arenas, MD, PhD²; Carlos Vozzi, MD³; Gervasio A. Lamas, MD^1,4

¹Columbia University Division of Cardiology at Mount Sinai Medical Center, Miami Beach, Florida;²Department of Cardiology, Salem Health, Salem, Oregon; ³Cardiologia, Instituto Vozzi, Rosario, Argentina; ⁴Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, Florida

Francisco Ujueta, MD, MS1; Ivan A. Ar...

Outcomes of CLTI patients with diabetes who underwent edetate disodium-based infusions.

Outcomes of CLTI patients with...

05/16/2022

Vascular Disease Management